Q3 2020 Applied Genetic Technologies Corp Earnings Call
שיחת ועידה Applied Genetic Technologies Corp
Applied Genetic Technologies Corp Conference call or earnings call will be held on 13/05/2020 via an 800 number (toll-free). During the earnings conference call's session Applied Genetic Technologies Corp will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Applied Genetic Technologies Corp for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a clinical-stage biotechnology company using gene therapy based on adeno-associated virus, or AAV, to develop genetic therapies to treat patients with inherited diseases. Each treatment is precisely designed to address a specific genetic disorder. Our most advanced gene therapy programs are designed to produce treatments that will restore visual function in patients with rare blinding diseases. Genetic therapies are complex with interdependent components that must work in harmony. Fifteen years of gene therapy experience allows us to design and construct all critical gene therapy components and bring them together to develop potentially effective treatments for patients. We are committed to attracting and maintaining a team with a substantial breadth of clinical and scientific expertise who can foster an atmosphere of scientific growth and discovery.קרא עוד שיחת ועידה